MedPath

Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection (CRP-Track)

Not Applicable
Completed
Conditions
Colorectal Postoperative Complication
Interventions
Other: C-reactive protein dosage
Registration Number
NCT02395380
Lead Sponsor
Centre Hospitalier Departemental Vendee
Brief Summary

Colic and rectal resection represents a majority of hospitalizations in visceral surgery. The objective of this study was to evaluate the prognostic of inflammatory markers dosage (CRP, procalcitonin and venous lactate) on the postoperative recovery after colorectal surgery and on the length of stay.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
176
Inclusion Criteria
  • Upper age to 18 years
  • Planned hospital stay for a colonic resection with anastomosis without permanent or temporary digestive bypass
  • Patient with pre-operative CRP lower or egal to 172 mg/L
  • No opposition at the participation of the study
  • Expected patient return home after surgery (or convalescent home or not medicalized institution)
Exclusion Criteria
  • Patient under guardianship
  • Protected or private patient freedom
  • Minor patient
  • Colectomy surgery with digestive bypass or digestive anastomosis
  • Complex combined surgery (significantly intestinal resection associated, another surgical procedure that can interfere with postoperative CRP)
  • General inflammatory disease susceptive to modify dosage values
  • Anti-inflammatory therapy (AINS/ corticosteroids/ immunosuppressive)
  • Patient unable to understand the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
C-reactive protein dosageC-reactive protein dosage-
Primary Outcome Measures
NameTimeMethod
C-reactive protein rate3 postoperative days

The time of postoperative recovery will be compared to the CRP values at 3 postoperative days.

The postoperative recovery is a composite endpoint defined by :

* no pain \> 2 on the VAS scale

* presence of a gaseous bowel

* patient autonomy in terms of ambulation and body care (IRM 5-6)

* no fever

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Centre Hospitalier Departemental Vendee

🇫🇷

La Roche sur Yon, France

CHU Nantes

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath